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Abstract
Recently developed atrophic non-union models are a good representation of the clinical situation in which many non-
unions develop. Based on previous experimental studies with these atrophic non-union models, it was hypothesized that in
order to obtain successful fracture healing, blood vessels, growth factors, and (proliferative) precursor cells all need to be
present in the callus at the same time. This study uses a combined in vivo-in silico approach to investigate these different
aspects (vasculature, growth factors, cell proliferation). The mathematical model, initially developed for the study of normal
fracture healing, is able to capture essential aspects of the in vivo atrophic non-union model despite a number of deviations
that are mainly due to simplifications in the in silico model. The mathematical model is subsequently used to test possible
treatment strategies for atrophic non-unions (i.e. cell transplant at post-osteotomy, week 3). Preliminary in vivo experiments
corroborate the numerical predictions. Finally, the mathematical model is applied to explain experimental observations and
identify potentially crucial steps in the treatments and can thereby be used to optimize experimental and clinical studies in
this area. This study demonstrates the potential of the combined in silico-in vivo approach and its clinical implications for
the early treatment of patients with problematic fractures.
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Introduction
Atrophic non-unions, a class of non-healing fractures that
display only limited external callus formation, were thought to
occur as a result of impaired local blood supply [1,2]. However,
studies of human atrophic non-unions have shown that the gap
tissues can be well vascularized [3–5]. Recently several animal
models were developed to investigate the etiology of atrophic non-
unions [6–9]. In these animal models, the periosteum disruption
and reaming of the marrow canal is combined with adequate
stabilization of the osteotomy site. All models demonstrate
established non-unions. These animal models are a good repre-
sentation of the clinical situation in which most atrophic non-
unions develop [8]. Previous non-union models often utilized large
segmental bone defects [10–13] where non-unions developed due
to the size of the defect rather than the altered biology of the
fracture site [8].
Based on previous, purely experimental, studies with these
atrophic non-union models, it was hypothesized that in order to
obtain successful fracture healing, blood vessels, growth factors
and (proliferative) precursor cells all need to be present in the
callus at the same time [6,7]. In this study we will use a combined
in vivo-in silico approach to look at these different aspects
(vasculature, growth factors, cell proliferation). Furthermore, the
in silico model is used to investigate the occurrence of and design
possible treatment strategies for atrophic non-unions. Experimen-
tal results (original work and previously published) are used to
corroborate the numerical predictions for atrophic non-unions in
particular and demonstrate the potential of both the in silico-in vivo
approach and the treatment strategy of cell transplantation.
Finally, the mathematical model is applied to explain experimental
observations and identify potentially crucial steps in the treat-
ments.
Materials and Methods
Ethics statement
Rats were kept in accordance with UK Home Office welfare
guidelines and project license restrictions.
Animals and operative procedure
Animals and operative procedures were carried out as
previously reported [7]. In brief, 28 adult female Wistar rats were
randomised into 2 groups of 14 (‘non-union’ and ‘healing’) and
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and the right (operated) tibia was prepared for histological
examination. The animals were caged individually and allowed
water and food ad libitum and unrestricted weight-bearing.
A standardised circular frame external fixator [7] was applied to
the right tibia under general anaesthesia and with aseptic
conditions. An osteotomy was performed using a 1mm burr
under constant irrigation with cold saline solution. The fibula was
fractured manually using a three-point bending method and a
1 mm gap introduced at the site of the osteotomy. In 14 of the 28
animals the periosteum was stripped and the intramedullary canal
was curetted, both proximally and distally, for a distance
equivalent to 1 tibial diameter. The wound was washed thoroughly
and the skin was closed.
Two independent senior orthopaedic trainees assessed stan-
dardized radiographs obtained after operation and every two
weeks thereafter. They categorized the fractures as healing or not
according to the criteria of the AO-ASIF manual [2].
Cell transplant
Atrophic non-union was induced in 8 WKY rats as previously
described [7]. Three weeks after operation, 4 rats received a
100 ml injection at the non-union site of cultured bone marrow
cells and 4 rats received a 100 ml injection of carrier solution alone.
Bone marrow cells were obtained by aspiration of the hind limbs
of WKY rats and processed for injection as described in (a full
description of this protocol is submitted for publication elsewhere).
Two oblique radiographs were taken of the right (operated) tibia
post-operatively and at 2 weeks, 3 weeks (immediately following
cell/carrier injection) and every week thereafter. Radiographs
were examined by two independent senior orthopaedic trainees.
Each animal was categorized as healing or not (full report of results
submitted for publication elsewhere).
Measurement of callus formation
Formation of callus was assessed by scanning radiographs into a
Macintosh Quadra 650 computer and analyzing images (Optilab
Pro v2.5, Graftek, France). The callus outline was traced manually
and the size of the outlined area was calculated. The results were
expressed as a percentage change in the amount of mineralized
tissue from post-operative radiographs [7].
Histology and immunohistochemistry
The right lower limbs were fixed in neutral phosphate-buffered
formalin (4% v/v) for 48 hours, decalcified in neutral ethylene-
diaminotetra-acetic acid (EDTA), embedded in paraffin wax and
6mm sections were cut and stained with haematoxylin and eosin.
Wax sections for immunohistochemistry were cut onto poly-l-
lysine coated slides and immunostaining was performed with the
following antibodies: Transforming growth factor beta (TGF-b)
(mouse monoclonal, AbD Serotec Ltd, Oxford, UK), Basic
Fibroblast Growth Factor (FGF basic) (goat polyclonal, Santa
Cruz Biotechnology Inc. USA), Platelet-Derived Growth Factor
(PDGF) (goat polyclonal, R&D Systems Ltd, Abingdon, UK),
Bone Morphogenetic Proteins 2 and 4 (BMP 2/4) (goat polyclonal,
R&D Systems Ltd, Abingdon, UK), and Proliferating Cell Nuclear
Antigen (PCNA) (mouse monoclonal, Dako Ltd, Ely, UK).
Alkaline phosphatase-conjugated anti-mouse (Dako, Ely, UK) or
anti-goat (Sigma, Poole, UK) secondary antibodies were used. Cell
transplant samples labelled with BrdU were prepared as above,
followed by immunostaining with antibodies against BrdU (mouse
monoclonal, Dako Ltd, Ely, UK) in conjunction with an animal
research kit (ARK, Dako Ltd, Ely, UK). All antibodies were used
according to the manufacturer’s instructions.
Sections were analyzed using a light microscope. Cytoplasmic
growth factor expression was semi-quantified using a four-value
intensity score (0, 1+,2 +, and 3+) [14]. For proliferating cells, the
numbers of positively and negatively stained cells were counted in
randomly selected fields within the interfragmentary gap and the
median positive staining index was calculated.
Statistics
A Mann-Whitney U test was used to assess significance of the
cell proliferation results. All statistical analyses were performed
using the Statview software package (SAS Institute Inc., USA) and
significance was assumed as p,0.05.
Mathematical modelling
The mathematical model used in this study was originally
developed to describe normal fracture healing [15]. It expresses
the change of a number of continuum-type variables – growth
factor concentrations, cell densities and matrix densities – as a
function of time and spatial coordinates and is schematically
represented in Figure 1. The model accounts for various key
processes of bone regeneration. Starting with a callus filled with
granulation tissue, mesenchymal stem cells and growth factors
quickly occupy the regeneration zone. This is followed by
mesenchymal stem cell differentiation into osteoblasts (intramem-
branous ossification – close to the cortex away from the fracture
site) and chondrocytes (central callus region). Subsequently,
endochondral ossification can take place during which VEGF,
expressed by (hypertrophic) chondrocytes, attracts blood vessels
and osteoblasts, resulting in cartilage degradation and bone
formation. Bone remodelling processes are not included in the
model. The effect of mechanical loading can also be incorporated,
by making various biological processes dependent on local
mechanical stimuli [16]. Mechanical influences will however not
be the subject of the current study.
The regeneration processes are described by calculating the
spatiotemporal evolution of the density of mesenchymal stem cells,
osteoblasts, chondrocytes, fibroblasts, endothelial cells, bone,
cartilage, fibrous tissue and vascular matrix and the concentrations
Author Summary
In light of the ageing population, the occurrence of bone
fractures is expected to rise substantially in the near future.
In 5 to 10% of these cases, the healing process does not
succeed in repairing the bone, leading to the formation of
delayed unions or even non-unions. In this study we used
a combination of an animal model mimicking a clinical
non-union situation and a mathematical model developed
for normal fracture healing to investigate both the causes
of non-union formation and potential therapeutic strate-
gies that can be applied to restart the healing process.
After showing that the mathematical model is able to
simulate key aspects of the non-union formation, we have
used it to investigate several treatment strategies. One of
these strategies, the treatment of a non-union involving a
transplantation of cells from the bone marrow to the
fracture site, was also tested in a pilot animal experiment.
Both the simulations and the experiments showed the
formation of a bony union between the fractured bone
ends. In addition, we used the mathematical model to
explain some unexpected experimental observations. This
study demonstrates the added value of using a combina-
tion of mathematical modelling and experimental research
as well the potential of using cell transplantation for the
treatment of non-unions.
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and vascular growth factors). The spatiotemporal dynamics is
expressed by means of a system of 12 partial differential equations
of the taxis-diffusion-reaction type. The system’s general structure
is:
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t represents the time,~ x x the space and~ c cm t,~ x x ðÞ the non-dimensional
density of a migrating cell type (mesenchymal stem cells, fibroblasts
and endothelial cells).~ c ct ,~ x x ðÞ represents the vector of the other nine
non-dimensional cell concentrations, ECM densities and growth
factor concentrations (for which no directed migration is modelled).
Dcm ~ c c ðÞand D (non-negative diagonal matrix) are the diffusion
coefficients (random motion). fi ~ c c ðÞrepresents the taxis coefficients
for both chemotaxis (movement up a gradient of growth factor
concentration) and haptotaxis (movement up a gradient of matrix
density). f0 ~ c cm,~ c c ðÞ and g ~ c cm,~ c c ðÞ are reaction terms describing cell
differentiation, proliferation and decay and matrix and growth
factor production and decay. The system (1) must be complemented
by suitable initial and boundary conditions to ensure the existence,
uniqueness and non-negativity of a solution ~ c cm t,~ x x ðÞ ,~ c ct ,~ x x ðÞ ðÞ . The
model equations are implemented in a customized finite volume
code [17]. Additional information, including the complete set of
equations, boundary and initial conditions, parameter values and
implementation details, is provided in the Supplementary Methods
(Text S1) and Geris et al. [15]. For a detailed discussion of the
model’s underlying assumptions, simplifications and shortcomings,
we refer the reader to Geris et al. [15,16]. Non-union cases were
previously simulated by compromising the initial blood vessel or
growth factor supply [15] or by applying increased mechanical
loading (instability) on the fracture [16]. In all cases, the simulations
were able to capture observed experimental and clinical outcomes.
Moreover, in silico experiments were conducted to design potential
treatment strategies for the various non-union models [15,18,19]
however, these predictions were not corroborated by dedicated
experiments as is the case in this study.
A simplified (fixed) geometrical domain of a fracture callus
(Fig. 2A,B) was constructed based on the experimental set-up [7].
For the atrophic non-union case the domain was extended at the
distal end (away from the fracture site) over the distance that the
periosteum was stripped and the marrow canal was reamed in the
experiments. The current implementation of the model assumes a
constant callus size for both healing and non-union groups
(Fig. 2B). The experimentally observed callus size for both healing
and non-union groups is described in [7]. For the non-union group
there was a trend towards a decrease of the callus-size (by 10%)
over time, though this was not a statistically significant decrease.
Figure 1. Schematic representation of the mathematical model. Legend: GF=growth factor, m=mf + mc + mb + mv=total tissue density,
X=maximum tissue density for proliferation. The involvement of a variable in a regeneration subprocess is indicated by showing the name of that
variable next to the arrow representing that particular process, e.g. the vascular matrix density (mv) interferes with cell migration, endochondral
ossification and GF production.
doi:10.1371/journal.pcbi.1000915.g001
Integrative Approach to Bone Atrophic Non-Unions
PLoS Computational Biology | www.ploscompbiol.org 3 September 2010 | Volume 6 | Issue 9 | e1000915Figure 2. Mathematical modelling of the regeneration process in healing and non-union groups. (A) Domain of the simulations. 1:
periosteal callus; 2: intercortical gap; 3: endosteal callus; 4: cortical bone. (B) Boundary conditions for healing and non-union model. MSC:
mesenchymal stem cells; FB: fibroblast; OB: osteoblast; EC: endothelial cell; CGGF: chondrogenic growth factor; OGGF: osteogenic growth factor. (C)A
comparison of experimentally measured (Exp) [7] and numerically calculated (Sim) tissue constituents present within the interfragmentary gap of
healing and non-union groups (stacked bars). (D) Temporal evolution of the numerically calculated tissue fraction for the healing group. The insert
shows the interfragmentary region of the simulation domain. (E) Temporal evolution of the numerically calculated tissue fraction for the healing
group with reduced (by factor 10) cartilage (Pcs) and bone matrix (Pbs) production rates leading to a better correspondence between experimental
and simulation results.
doi:10.1371/journal.pcbi.1000915.g002
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(lack of) granulation tissue containing the necessary MSCs plays an
important role in the formation of a non-union. Therefore, in
order to simulate the formation of an atrophic non-union, the
boundary condition for the MSCs was adapted (value of the
Dirichlet boundary conditions was decreased with a factor 10
5)
while all other model parameters and initial/boundary conditions
were left unchanged with respect to the normal healing case. As
the initial mechanical conditions for both the healing and non-
union group were equal, the influence of mechanical loading was
not taken into account explicitly in this study (the bioregulatory
model presented in [15] was used rather than an extended
mechanobioregulatory model presented in [16]). After initial
analyses, the values for the growth factor boundary conditions
(which were estimated in [15]) were lowered by a factor 10 in this
study (for both the healing and non-union case) to obtain a better
correspondence with experimental results (for both healing and
non-union case). This alteration only affected the average growth
factor concentration during the first weeks of the healing process
but had no effect on the amount and distribution of the cells and
extracellular matrix. For all simulations cartilage and bone matrix
formation rates were equal to the values reported in [15], apart
from a case in which these values were lowered by a factor 10.
This was done in order to investigate the effect on the healing rate.
For all the simulated treatment strategies, 1ml of MSCs was
administered at a concentration of 10
6 cells/ml.
Tissue fractions were calculated from the bone, cartilage and
fibrous tissue matrix densities in the central area of the domain,
corresponding to the experimentally investigated region of interest
(i.e. excluding those parts of the domain stretching out to the right
alongside the cortex, see insert in Fig. 2D).
Results
When simulating the healing process on a fracture where either
the periosteum was stripped or the marrow canal was reamed,
complete fracture healing was predicted to occur with delayed
bone formation in those parts of the callus domain where the MSC
source was removed. Only when both modifications were
combined (Fig. 2A,B) the occurrence of a non-union was predicted
(Fig. 2C), suggesting that, from a modelling perspective, lack of
primitive cells due to the stripping of the periosteum and the
reaming of the intramedullary canal influences other processes
further downstream in the healing process, such as blood vessel
formation and growth factor production, leading eventually to a
non-union.
In silico and in vivo atrophic non-union model
The simulation results showed healing progression similar to
experimental results [7], for both the healing and the non-union
group (Fig. 2C). For the non-union group, the mathematical
model predicted the formation of small amounts of cartilage and
bone by post-osteotomy week (POW) 8. For the healing group,
both direct bone formation (close to the undamaged cortical bone)
and cartilage formation (central part of the callus) were predicted
to form by POW3 (Fig. 2D). By week 8 this cartilage was replaced
by bone via endochondral ossification in the simulations.
Reducing the cartilage and/or bone matrix formation rate in
the mathematical model resulted in a slower ossification process
(Fig. 2E).
As blood vessels are represented in the mathematical model by a
continuum variable, the amount of vessels itself cannot be
quantified from the simulation results. Instead, the percentage of
vascularized tissue was calculated. Due to the absence of the
vasculogenesis process (i.e. process of blood vessel formation
occurring by a de novo production of endothelial cells in contrast to
angiogenesis where blood vessels are formed from pre-existing
ones [20]) in the mathematical model, blood vessel formation only
appeared at the onset of osteogenesis (week 1) (Fig. 3A,B). By 8
weeks, the non-union group reached the level of vascularisation
that was present in the healing group at 3 weeks (Fig. 3B).
In the experimental non-union group, cell proliferation was at
its highest one-week post-osteotomy, with PCNA positive cells
present throughout the interfragmentary gap. The number of
PCNA positive cells within the interfragmentary gap diminished at
3 and 8 weeks post-osteotomy (Fig. 3C,E). In the healing group,
cell proliferation peaked at week 3, where PCNA positive cells
were present in the periosteum and at the edge of the ossification
front (Fig. 3E). By 8 weeks the number of PCNA positive cells had
diminished, and they were only evident in the periosteum at the
periphery of the bridging callus.
In the numerical simulations, rapid proliferation of the MSCs at
the onset of the healing process spiked the value for cellular
proliferation in the first week for the healing group in contrast to
the non-union group (Fig. 3D). After differentiation into
chondrocytes in the central part of the callus and subsequently
into osteoblasts, the cellular proliferation dropped in the healing
group. Fibroblasts are the predominant cell type in the non-union
group and as the predicted fibrous tissue density was not as high as
that of bone or cartilage (leaving less space for cell proliferation) for
the healing group, the non-union group was predicted to have a
higher proliferative capacity at POW 8 compared to the healing
group, corresponding to experimental in vivo observations.
At POW 1, the hematoma within the interfragmentary gap of
the in vivo experimental healing and non-union groups stained
positively for TGF-b, FGF-b, PDGF and BMP 2/4, however,
TGF-b and FGF-b staining of the hematoma in the non-union
group appeared weaker than that of the healing group (Fig. 4A
and Figure S1). At POW 3, staining of all four growth factors was
evident in areas of endochondral ossification in the healing group,
where both osteoblasts and chondrocytes were expressing these
growth factors. In the non-union group, however, TGF-b,F G F - b
and BMP 2/4 staining had diminished in comparison to the one
week time point. At 8 and 16 weeks (identical results were
obtained for both time points), there was either weak or absent
staining of all four growth factors in the healing group, due to
bridging callus. In the non-union group, weak staining of all 4
growth factors remained in the fibrous tissue of the interfrag-
mentary gap.
In the mathematical model, generic, functional families rather
than specific growth factors were implemented. The average
concentration for each generic growth factor group was calculated
for the central area of the domain (indicated on insert in Fig. 2D).
In Figure 4B, the experimentally measured growth factors for the
healing group are depicted according to their classification in
generic growth factor families by Cho et al. [21], Pepper et al. [22]
and Lienau et al. [23]. Osteogenic growth factors are expressed
early on in the healing process during intramembranous
ossification. Later on, an increase in their production is predicted
during the endochondral ossification process. For the vascular
growth factors, after the initial decrease, upregulation is predicted
during the endochondral ossification process taking place in the
healing group, where VEGF is being expressed by (hypertrophic)
chondrocytes. For both the healing and non-union groups, the
highest levels of chondrogenic growth factors are predicted by the
mathematical model in the first week, similar to the experimental
measurements. For the non-union group (Fig. 4C), after the initial
growth factor release at fracture induction, some chondrogenic
Integrative Approach to Bone Atrophic Non-Unions
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Osteogenic growth factor production is predicted to rise between
POW3 and POW8 in the non-union group, as experimentally
observed.
Treatment strategies for atrophic non-unions
After corroboration of the mathematical model, we wanted to
test, both in silico and in vivo, the hypothesis that the onset of
atrophic non-union could be prevented by the injection of cultured
MSCs at three weeks post-osteotomy, i.e. when vascularity within
the interfragmentary gap was sufficient to keep the injected cells
alive. In silico, after the injection of the cell transplant at POW 3 in
the callus region, the amount of bone was predicted to gradually
increase whereas the amount of fibrous tissue was predicted to
decrease up to POW 16. The formation of a small amount of
cartilage was also predicted with endochondral ossification still in
progress at POW 16 (Fig. 5Ai,Aii). The amount of soft tissue
present at POW 16 was strongly dependent on the exact location
Figure 3. Vascularisation and cell proliferation in healing and non-union groups. (A) Comparison of the median number of blood vessels
between the healing and non-union groups [7]. (B) Percentage of vascularised tissue in the callus as calculated by the mathematical model. (C)A
comparison of the number of PCNA positive cells within the interfragmentary gap at 1, 3, 8 and 16 weeks post-osteotomy between healing and non-
union groups. (D) Cellular proliferation for the healing and non-union set-ups, as calculated by the mathematical model. (E) PCNA expression
indicating cell proliferation in the fracture area. For the healing group PCNA expression is found along the edge of callus formation in the periosteum
(arrows) and within the interfragmentary tissue (IT) at POW1 (magnification 6100) and along the callus ossification front (arrow) and within the
interfragmentary tissue at POW3 (magnification 6100). The non-union group shows PCNA stained cells in the interfragmentary gap at POW1
(magnification 6400) and PCNA positive cells surrounding areas of active bone resorption at POW3 (magnification 6400). CB=cortical bone.
doi:10.1371/journal.pcbi.1000915.g003
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PLoS Computational Biology | www.ploscompbiol.org 6 September 2010 | Volume 6 | Issue 9 | e1000915Figure 4. Growth factor expression in healing and non-union groups. (A) A comparison of growth factor staining index (based on
immunohistochemical analysis) within the interfragmentary gap at 1, 3, 8 and 16 weeks post-osteotomy between healing and non-union groups. (B)
Relative variation of the density of the generic osteogenic, chondrogenic and vascular growth factor density as calculated by the mathematical model
for the healing group (full line) and reported in literature (dash-dotted line) [21–23]. Bars represent the experimentally measured growth factor levels
of the growth factors belonging to these functional families (according to [21–23]) for the normal healing group. (C) Relative variation of the density
of the generic osteogenic, chondrogenic and vascular growth factor density, as calculated by the mathematical model for healing and non-union set-
ups. Experimentally measured (bars) growth factor variations of growth factors belonging to these functional families (according to [21–23]) are
depicted as well.
doi:10.1371/journal.pcbi.1000915.g004
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unicortical bridging (Fig. 5Bi,Bii). A technique often used to
administer growth factors to healing fractures is the administration
of growth factors inside an injectable carrier close to but outside of
the callus (reviewed in [24]). Alternatively, one could adopt such a
carrier approach for cell delivery as well. However, simulating
such a treatment strategy predicted the formation of a layer of
bone closest to the cell source, preventing other cells from further
penetrating the callus (Fig. 5c).
Discussion
In the simulations, a combination of periosteal stripping and
marrow canal curettage led to non-union formation, thereby
Figure 5. The effects of MSC transplantation on atrophic non-union. (Ai) Simulation results for the treatment with the cell transplant
injected in the centre of the callus. (Aii) A comparison of experimentally measured (Exp) and numerically calculated (Sim) tissue constituents present
within the interfragmentary gap of control (carrier solution injected) and treatment (MSC transplant) groups (
o*p ,0.005, students t-test). Simulation
results are shown for a central injection of the carrier solution. (Bi) Simulation results for the treatment with the cell transplant injected excentrally in
the callus. (Bii) A comparison of experimentally measured (Exp) and numerically calculated (Sim) tissue constituents present within the
interfragmentary gap of control (carrier solution injected) and treatment (MSC transplant) groups (
o*p ,0.005, students t-test). Simulation results are
shown for an excentral injection of the carrier solution. (C) Simulation results for the treatment with the cell transplant injected outside the callus. (D)
Histological section (H&E) showing full bony callus bridging of the posterior (P) aspect of the tibia but no bony bridging at the anterior (A) aspect.
Original bone ends marked *. An area of endochondral ossification (arrow) is present at the anterior aspect of the tibia. Images taken at 620
magnification.
doi:10.1371/journal.pcbi.1000915.g005
Integrative Approach to Bone Atrophic Non-Unions
PLoS Computational Biology | www.ploscompbiol.org 8 September 2010 | Volume 6 | Issue 9 | e1000915predicting the observed in vivo outcome, where all animals that had
periosteal stripping and curettage of the intramedullary canal went
on to form an atrophic non-union at 8 and 16 weeks post-
osteotomy and all animals where this was not performed went on
to unite successfully [7]. At 1 week there was no significant
difference in tissue constituents between the two experimental
groups. However, from 3 weeks onwards, there was a significant
increase in bone formation in the healing group when compared
to the non-union group where the interfragmentary gap consisted
predominantly of fibrous tissue. The model did not predict the
experimentally observed rounding of the cortical bone ends in the
non-union group, nor the capping of the intramedullary canal.
The cortical bone falls outside of the modelling domain so changes
in the cortical bone cannot be predicted by the model. The
mechanism which causes the capping of the intramedullary canal
is not known and does not seem to be encompassed by the present
model equations either.
Although the order of fracture healing events in the simulations
corresponds to experimental observations, the normal healing
enrolled faster in the simulations than in the experiments [7]. As
the predicted time frame of healing as well as the predicted tissue
pattern correspond well to other rat fracture models [8,25], we
speculate that this difference might be attributed to a number of
factors that are specific for this experimental set-up. The initial
delay between experimental observations and numerical simula-
tions is one week (Fig. 2D). This could be due to a particularly
lengthy inflammatory phase in this specific experimental set-up, a
phase that is not incorporated explicitly in the mathematical
model. After POW 3, the endochondral ossification process enrolls
much faster in silico than in vivo increasing the time delay between
experiments and simulations. Decreasing the endochondral
ossification speed in silico by e.g. reducing the cartilage and bone
matrix production rate in the model leads to a better correspon-
dence between experiments and simulations (Fig. 2E). For all other
simulation results shown in this study the original values for
cartilage and bone matrix production rates as determined in [15]
were used.
Similar to the experimental observations [7], by 8 weeks, the
non-union group reached the level of vascularisation that was
present in the healing group at 3 weeks (Fig. 3B). The slower
vascularisation of the simulated non-union with respect to its
experimental counterpart could be due to the absence of de novo
blood vessel formation (vasculogenesis) in the mathematical model
combined with the absence of vascular growth factor production
by fibroblasts, leading to a slow build-up of the vascular network.
The experimentally observed decrease in number of blood vessels
during bone/blood vessel remodelling at POW 8 (which is often
accompanied by an increase in vessel diameter, a parameter that is
not included in the experimental measurements) cannot be
predicted as the model does not encompass the remodelling
process. Despite these limitations, the mathematical model does
predict a substantial time difference in the vascularisation of the
callus area as shown by the (also experimentally observed) lag in
blood vessel formation between healing and non-union groups at
POW 3.
Cell proliferation observed in the in vivo healing group,
concurred well with that observed by Iwaki et al. [26] where
proliferating cells peaked between 1 and 3 weeks after fracture. For
the proliferation, no exact match to the experimental measure-
ment could be obtained from the simulation results. A general
cellular proliferation value was calculated by multiplying the cells
in the callus by their respective proliferation rates (which are fixed
parameters in the mathematical model), normalized to total cell
amount and the maximal proliferation rate. As all cells in the
mathematical model are able to proliferate, providing there is
sufficient space surrounding them (i.e. ECM density is sufficiently
low), this calculated value is merely a theoretical one. The initial
low density fibrous matrix present at the start of the healing
simulations allows for rapid proliferation of the MSCs, spiking the
value for cellular proliferation in the first week for the healing
group in contrast to the non-union group where very few MSCs
were present (Fig. 3D). The formation of differentiated tissue types
such as bone and cartilage constrained the proliferation of the cells
later on in the regeneration process for the healing group. As the
fibrous matrix that develops in the non-union group does not
reach the density of the bone or cartilage in the healing group, the,
mainly fibroblastic, cells in the former group had a higher
proliferative capacity at POW 8 compared to the latter, as
observed in vivo.
Growth factor expression observed experimentally during the
early stages of bone healing correlated well with other studies
reporting BMP [27], TGF-b [28], and FGFb [28,29] expression in
normally healing rat fracture models, and PDGF expression in
normal and impaired human fracture healing [30]. Furthermore,
these results correlate with those of Brownlow et al. [6] who noted
in a rabbit atrophic non-union model that by POW 8, there was
little or no expression of TGF-b, FGFb, PDGF or BMP 2/4. Cho
et al. [21], Pepper et al. [22] and Lienau et al [23] classified growth
factors in functional families, similar to those used in the
mathematical model. The reported evolution over time of these
growth factor families corresponds well to the model predictions
for the healing group (Fig. 4B). For the vascular growth factors,
after the initial decrease, upregulation is predicted during the
endochondral ossification process taking place in the healing
group, where VEGF is being expressed by (hypertrophic)
chondrocytes, corresponding well to previously reported experi-
mental observations [31]. The experimentally observed decrease
in osteogenic growth factors after week 3 is not present in the
model as the osteoblasts remain active (i.e. keep producing growth
factors). Addition of a supplementary variable representing the
matured osteoblasts (osteocytes) could resolve this discrepancy
between experiments and simulations. For the non-union group,
the osteogenic growth factor levels are predicted to rise between
POW3 and POW8, corresponding to experimental in vivo
observations. Furthermore, the simulations show occurrence of
the highest levels of chondrogenic and vascular growth factors in
the first week, as experimentally observed. In the mathematical
model chondrocytes are the only cell type capable of chondrogenic
growth factor production and the main responsible for the
production of vascular growth factor (upon hypertrophy). As
chondrocytes are predicted to be only marginally present in the
callus of the non-union group, the predicted chondrogenic and
vascular growth factor concentrations further on in the healing
process are very low for this group in comparison to the growth
factor release at fracture induction. Furthermore, for the non-
union group, initial growth factor concentrations are strongly
driven by boundary conditions that were applied during the first
days after fracture to mimic local and systemic reactions occurring
outside of the modelling domain [32,33].
Comparison of experimental and simulation results showed a
number of discrepancies that could be attributed to a number of
model simplifications and suggestions were made above to
overcome those. Additional model simplifications were made in
the framework of this study such as the use of a fixed callus size
(rather than a size that varies over time) and the continuum
representation of blood vessel formation, which will be dealt with
in future versions of the mathematical model. For a thorough
discussion on the model limitations we refer the reader to [15]. In
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initial mechanical situation was the same for both the healing and
the non-union group. During the healing process, the development
of stiffer tissues such as bone might alter the local mechanical
conditions in the healing group thereby possibly influencing the
healing process. However, under normal mechanical conditions
(i.e. appropriate external stabilisation that allows for normal
healing to occur) the bioregulatory model used in this study [15]
behaves the same as an extended mechanobioregulatory variant
[16] that incorporates mechanical loading explicitly.
The use of stem cells in the treatment of non-unions is gaining
interest (reviewed in [34]). However, to date these stem cells were
delivered in a (ceramic) scaffold or carrier structure requiring
invasive surgery. Non-invasive techniques such as direct injection
of a cell-buffer mixture or the use of injectable carriers could
substantially reduce the additional trauma for the patient and were
investigated by an in silico – in vivo approach in this study. As blood
vessel formation is delayed in the non-union group, the most
suitable time point for intervention of either growth factor
treatment or cell transplant, seems to be three weeks post-
osteotomy, when the blood supply to the interfragmentary gap has
started to recover. Injection of MSCs directly into the callus area
elicited to a good healing response in silico. Experimental results
confirmed that transplantation of MSCs into the interfragmentary
gap at POW 3 prevented the onset of an atrophic non-union.
There was significantly more bone present in the treatment group
(cell transplant) than in the control group (carrier solution). Union
by bridging callus had occurred in three of the four treatment
animals. Yet, all of the animals treated by MSC transplantation
displayed an asymmetric healing with endochondral ossification in
progress in part of the intercortical callus (Fig. 5D). As the zone of
endochondral ossification was not always observed on the same
aspect of the tibia (anterior vs posterior), mechanical loading was
ruled out as the major cause. The in silico experiments carried out
in the framework of this study identified another potential cause,
namely injection of the cell transplant excentrally in the callus.
Upon excentral injection at POW 3, cartilage undergoing
endochondral ossification was predicted to be present at the
intracortical gap opposite the injection site at POW 16 (Fig. 5Bi).
The predicted amount of soft tissues present in the callus in that
case agreed well with the experimentally measured amount
(Fig. 5Bii). The use of an injectable carrier to deliver the cells
close to the fracture healing site did not generate a good healing
response in silico. The limitation of the MSCs’ migration speed due
to the fibrous extracellular matrix that has formed during the first
three weeks is not problematic in case of injection directly into the
callus area. However, this does become an issue when the cells are
administered in a carrier close to (but not within) the fracture site.
MSCs entering the callus area start differentiating under the
influence of the growth factors that are present. As the cells
migrate slowly into the callus area, they become differentiated
before they reach the central area of the callus. Differentiated cells
deposit bone matrix to replace the fibrous matrix which further
decreases the migration speed of the cells that enter the callus area
while the osteogenic growth factors that are expressed enhance the
differentiation, resulting in a layer of bone close to the cell source
while fibrous tissue persist in the major part of the callus area.
In this study we have shown that a mathematical model, initially
developed for normal fracture healing, can be used as a clinical
tool to investigate aetiology and treatment of atrophic non-unions.
Despite a number of deviations mainly due to simplifications in the
model, the mathematical model is able to capture essential aspects
of the atrophic non-union as observed experimentally in vivo.
Interestingly, the correspondence between simulations and
experiments was obtained without changing the previously
established parameter values, which clearly adds to the model’s
potential. Moreover, the model can be used to design treatment
strategies, assist in the interpretation of experimental observations
and test in silico various hypotheses in order to explain unexpected
experimental results. Following such a combined in silico-in vivo
approach may help to optimize experimental and clinical studies
in this area.
Supporting Information
Figure S1 Growth factor expression in healing and non-union
groups. Immunohistochemical analysis of TGF-beta, FGF-b,
PDGF and BMP2/4 in healing and non-union groups at 1 and
3 weeks post-osteotomy. Images taken at 620 or 640 magnifica-
tion and positive growth factor staining is seen as a red signal.
Found at: doi:10.1371/journal.pcbi.1000915.s001 (6.59 MB TIF)
Text S1 This file contains a detailed description of the
mathematical model used in this study including the full set of
equations, parameter values, boundary & initial conditions and
implementation details.
Found at: doi:10.1371/journal.pcbi.1000915.s002 (0.67 MB
DOC)
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